Literature DB >> 19368960

Use of low molecular weight heparin for thromboprophylaxis in a pediatric inpatient population: reasons for use and incidence of bleeding complications.

Matthew Cavo, Wei Wang, Sarah H O'Brien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19368960     DOI： 10.1016/j.thromres.2009.03.004

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  3 in total

1.  Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.

Authors:  Marie-Claude Pelland-Marcotte; Nour Amiri; Maria L Avila; Leonardo R Brandão
Journal:  Cochrane Database Syst Rev       Date:  2020-06-18

Review 2.  Venous Thromboembolism in Critical Illness and Trauma: Pediatric Perspectives.

Authors:  Ranjit S Chima; Sheila J Hanson
Journal:  Front Pediatr       Date:  2017-03-13       Impact factor: 3.418

3.  Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report.

Authors:  A Parker Ruhl; S Christy Sadreameli; Julian L Allen; Debra P Bennett; Andrew D Campbell; Thomas D Coates; Dapa A Diallo; Joshua J Field; Elizabeth K Fiorino; Mark T Gladwin; Jeffrey A Glassberg; Victor R Gordeuk; Leroy M Graham; Anne Greenough; Jo Howard; Gregory J Kato; Jennifer Knight-Madden; Benjamin T Kopp; Anastassios C Koumbourlis; Sophie M Lanzkron; Robert I Liem; Roberto F Machado; Alem Mehari; Claudia R Morris; Folasade O Ogunlesi; Carol L Rosen; Kim Smith-Whitley; Danna Tauber; Nancy Terry; Swee Lay Thein; Elliott Vichinsky; Nargues A Weir; Robyn T Cohen; Elizabeth S Klings
Journal:  Ann Am Thorac Soc       Date:  2019-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.